Sisram Medical Ltd
SRAMF
$0.5512
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 12.49% | 12.49% | -42.05% | -42.05% | -35.55% |
| Total Depreciation and Amortization | 5.32% | 5.32% | 44.37% | 44.37% | 33.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -27.40% | -27.40% | 7.56% | 7.56% | -18.31% |
| Change in Net Operating Assets | -40.93% | -40.93% | -- | -- | 83.30% |
| Cash from Operations | -18.94% | -18.94% | -50.54% | -50.54% | 216.52% |
| Capital Expenditure | 73.61% | 73.61% | 58.92% | 58.92% | -67.88% |
| Sale of Property, Plant, and Equipment | -2,700.00% | -2,700.00% | 530.00% | 530.00% | 110.53% |
| Cash Acquisitions | 64.47% | 64.47% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -976.46% | -976.46% | 65.91% | 65.91% | 102.53% |
| Cash from Investing | -80.44% | -80.44% | 138.08% | 138.08% | 85.40% |
| Total Debt Issued | 85.48% | 85.48% | 49.87% | 49.87% | -16.98% |
| Total Debt Repaid | -35.98% | -35.98% | -5.55% | -5.55% | -20.44% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 10.09% | 10.09% | -- | -- | -12.71% |
| Other Financing Activities | 126.70% | 126.70% | 84.03% | 84.03% | 47.82% |
| Cash from Financing | 16.63% | 16.63% | 44.17% | 44.17% | -10.50% |
| Foreign Exchange rate Adjustments | 101.55% | 101.55% | 50.84% | 50.84% | -8.97% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -100.10% | -100.10% | 141.83% | 141.83% | 113.18% |